All stock lists
BillionToOne, Inc. (NASDAQ:BLLN)
US · Delayed Price · Currency is USD
Healthcare · Medical - Diagnostics & Research
110.79+3.02 (+2.80%)
Market cap
$5.23B
Health Score
Analyst consensus
Listed since
Nov 6, 2025
Website
Insider Score
––Not scored
BLLN Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
BLLN analyst forecast
BLLN analyst consensus
No analyst ratings in the last 3 months.
BLLN 12-month price target
$124.00+11.3% upsideaverage of 2 firms
$128.00High
$120.00Low
Best analysts covering BLLN
No firm covering BLLN has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
BLLN analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Guggenheim | — | $128.00 | +19.6% | — | 2026-10-01 | |
| Canaccord Genuity | — | $120.00 | +30.0% | — | 2026-09-02 |
BLLN earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-04 | 0.07 | 0.11 | $87.2M | $96.1M |
| 2026-05-06 | 0.01 | 0.34 | $97.1M | $108.4M |
| 2026-08-05 | 0.18 | 0.15 | $109.2M | $109.4M |
| 2026-11-04 | 0.15 | 0.00 | $115.8M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.